Last updated: June 28, 2026
ANEXSIA 5/325 (oxycodone 5 mg / acetaminophen 325 mg) suppliers: Who manufactures, supplies, and sources the drug and its active ingredients?
No complete, reliable “supplier map” can be produced for ANEXSIA 5/325 (oxycodone 5 mg/acetaminophen 325 mg) from the information provided.
Who supplies ANEXSIA 5/325 in the supply chain (API, finished dosage form, packaging)?
Answer: Not determinable from the available input.
API suppliers for oxycodone and acetaminophen
Answer: Not determinable from the available input.
Finished-dose manufacturer and contract manufacturing
Answer: Not determinable from the available input.
Bottling, packaging, and label/secondary packaging
Answer: Not determinable from the available input.
Which companies manufacture ANEXSIA 5/325 and their manufacturing sites?
Answer: Not determinable from the available input.
US manufacturing (if marketed in the US)
Answer: Not determinable from the available input.
EU/UK manufacturing
Answer: Not determinable from the available input.
LATAM/MENA/Asia manufacturing
Answer: Not determinable from the available input.
What is the Orange Book status of ANEXSIA 5/325 and who is listed as applicant?
Answer: Not determinable from the available input.
Is it listed as an NDA, ANDA, or 505(b)(2)?
Answer: Not determinable from the available input.
Which NDA/ANDA holder holds marketing authorization
Answer: Not determinable from the available input.
What generic suppliers could produce ANEXSIA 5/325 (and what filings would show it)?
Answer: Not determinable from the available input.
ANDA applicants for oxycodone/acetaminophen 5/325
Answer: Not determinable from the available input.
Paragraph IV challengers
Answer: Not determinable from the available input.
How do formulation and manufacturing controls affect supplier qualification for ANEXSIA 5/325?
Answer: Not determinable from the available input.
Solid oral tablet process dependencies
Answer: Not determinable from the available input.
Content-uniformity and dissolution risk drivers
Answer: Not determinable from the available input.
Controlled-substance handling and logistics
Answer: Not determinable from the available input.
What licensing or distribution agreements typically govern ANEXSIA 5/325?
Answer: Not determinable from the available input.
Brand owner vs. distributor structure
Answer: Not determinable from the available input.
Wholesaler and channel partner pattern
Answer: Not determinable from the available input.
Key Takeaways
- A supplier and manufacturer roster for ANEXSIA 5/325 cannot be generated from the information provided.
- API, finished-dose, and packaging suppliers require verifiable source data (e.g., regulatory listings, label/pack data, or procurement disclosures) not included in the input.
FAQs
- How can I identify the finished-dose manufacturer of ANEXSIA 5/325 from packaging?
Not determinable from the available input.
- Who typically supplies oxycodone HCl APIs for combination tablets with acetaminophen?
Not determinable from the available input.
- Where do buyers verify manufacturing sites for oxycodone/acetaminophen 5/325 tablets?
Not determinable from the available input.
- Do Orange Book listings show contract manufacturing for ANEXSIA 5/325?
Not determinable from the available input.
- How do procurement teams screen controlled-substance suppliers for oxycodone products?
Not determinable from the available input.
References
No sources were provided in the input.
